ANGO vs MAS · rev $292.5M vs P/E 18, rev $7.83B
AngioDynamics Inc (ANGO) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
ANGO currently screens at market cap $378.5M. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the ANGO and MAS stock pages for the full models.
Not investment advice.